Logo IDsolutions Contact Montpellier
Jobs
Documentation area
Contact
  • English
    • French
  • English
    • French
  • English
    • French
  • English
    • French
  • About us
  • Expertise
    Technology
    Liquid Biopsy
    Métrologie et Maintenance
  • Oncology
    DNA qualification
    dPCR Reagents
    Extraction solutions
    IDQUANT
    Quantification and standardization
    IDENTIFY
    Research tests
    IDNAPTEX
    Probes and primers
    Kits
    Automates
    Accessories
    IDXTRACT
    IDXTRACT-MAG
    IDXTRACT-MAG-FFPE
    IDEAL 96 High Purity Extraction Robot
    IDEAL 32 Extraction Robot
    IDWELL96
    IDELU96
    IDTIP96
    IDWELL32
    IDTIP32
    IDLYSE24
  • Infectiology
    Diagnostic devices
    qPCR Reagents
    Extraction solutions
    Respiratory infections
    Gastrointestinal infections
    MonkeyPox virus
    Kit
    ID™ SARS-CoV-2/Influenza Triplex
    iSolutions™ Essential Enteric Bacteria Fullplex qPCR
    iSolutions™ Enteric Bacteria & C. difficile Fullplex qPCR
    iSolutions™ Enteric Virus Fullplex qPCR
    iSolutions™ MonkeyPox Fullplex qPCR
    MAG FAST Extraction Kit
    ID™ One-Step LysMix
    Microbial Lysis Solutions
    Anti-inhibitor Elution Buffer
  • Partners
  • News
Logo IDsolutions Contact Montpellier
Jobs
Documentation area
Contact
  • English
    • French
  • English
    • French
  • English
    • French
  • English
    • French
  • About us
  • Expertise
    Technology
    Liquid Biopsy
    Métrologie et Maintenance
  • Oncology
    DNA qualification
    dPCR Reagents
    Extraction solutions
    IDQUANT
    Quantification and standardization
    IDENTIFY
    Research tests
    IDNAPTEX
    Probes and primers
    Kits
    Automates
    Accessories
    IDXTRACT
    IDXTRACT-MAG
    IDXTRACT-MAG-FFPE
    IDEAL 96 High Purity Extraction Robot
    IDEAL 32 Extraction Robot
    IDWELL96
    IDELU96
    IDTIP96
    IDWELL32
    IDTIP32
    IDLYSE24
  • Infectiology
    Diagnostic devices
    qPCR Reagents
    Extraction solutions
    Respiratory infections
    Gastrointestinal infections
    MonkeyPox virus
    Kit
    ID™ SARS-CoV-2/Influenza Triplex
    iSolutions™ Essential Enteric Bacteria Fullplex qPCR
    iSolutions™ Enteric Bacteria & C. difficile Fullplex qPCR
    iSolutions™ Enteric Virus Fullplex qPCR
    iSolutions™ MonkeyPox Fullplex qPCR
    MAG FAST Extraction Kit
    ID™ One-Step LysMix
    Microbial Lysis Solutions
    Anti-inhibitor Elution Buffer
  • Partners
  • News

The Role of Sport in Reducing the Risk of Cancer Recurrence

  • Lifestyle
  • Publié le 12/11/2025
Le rôle du sport dans la réduction du risque de récidive du cancer | ID SOLUTIONS

After a cancer diagnosis, every patient seeks to stack the odds in their favour to avoid recurrence.

While medical treatments and regular follow-up remain essential, one often underestimated factor plays a major role in this battle: physical activity.

At ID SOLUTIONS, a specialist in molecular research and diagnostic solutions, we know early detection is vital. But we also believe that patient support doesn’t end with screening. Leading an active lifestyle after cancer is key to full recovery.


A woman exercising in a gym

Statistics that speak for themselves

Scientific data are clear: physical activity performed after a cancer diagnosis significantly reduces the risk of recurrence. International studies show impressive results:

  1. Prostate cancer: on average a 57% reduction in recurrence risk.
  2. Colorectal cancer: a 49% decrease in recurrence risk.
  3. Breast cancer: a 43% drop in recurrence risk.

Beyond recurrence prevention, post-diagnosis physical activity is associated with about a 40% reduction in overall mortality for these three types of cancer. These benefits are observed even with moderate activity equivalent to 30 minutes of brisk walking, five times a week.

Moreover: increasing one’s physical activity level progressively after diagnosis—even starting from a low baseline—is linked to a significant reduction in mortality.

How does physical activity act against recurrence?

Optimising metabolism and reducing fatigue

Regular physical activity affects many physiological mechanisms that contribute to reducing recurrence risk and improving treatment tolerance.

It improves metabolism: better insulin sensitivity and blood-glucose regulation; better fatty-acid utilisation; muscle mass and bone density maintenance.

These combined effects prevent sarcopenia and functional loss often observed during treatments, and contribute to a lasting reduction in cancer-related fatigue.

Strengthening the immune system and improving body composition

In parallel, exercise stimulates the immune system: increased activity of natural killer cells and T lymphocytes, and shifts the immune response toward an anti-inflammatory profile. This modulation of the inflammatory environment helps maintain a biological terrain unfavorable to tumour progression.

Finally, by improving body composition and reducing fat, physical activity aids better treatment tolerance, reduces pain and enhances quality of life. It thus stands as an effective non-pharmacological therapy—studies show a 20–40% reduction in chronic fatigue—and supports physical and psychological autonomy recovery.


A man exerting himself on a weight training machine.

Professional and human accompaniment

As emphasised by Dr Jean-Marc Sène, a physician specialising in sport-health:

“A patient who takes up a sporting challenge discovers mental capacities they often did not suspect. Mental capacities are decisive in healing.”

Physical activity adapted to the individual must be framed within a structured approach, complementing medical supervision. Trained professionals, such as adapted physical activity educators or organisations like CAMI Sport & Cancer, offer programmes tailored to each patient’s capacity and profile.

Beyond movement, this support contributes to better psychological and social balance — essential factors for overall recovery.


A man is doing pull-ups on a weight machine.

Conclusion

Cancer disrupts one’s bearings, but physical activity helps regain control. Walking, breathing, moving: these simple acts contribute to rebuilding health and confidence. The goal is not performance but reconnecting with one’s body, guided by professionals and supported by science.

At ID SOLUTIONS, we know every innovation counts in the fight against cancer. Our expertise in molecular diagnostics aims to detect disease as early as possible, but we are convinced that holistic patient care also includes guidance towards an active lifestyle. Because behind every screening test, every analysis, there’s a person who deserves the best chances of recovery and a life without recurrence.

The message is clear: move, as soon as possible, as often as possible, and especially regularly. Even moderate activity is a massive gain compared to a sedentary state. Talk to your medical team, get support if needed, and give your body the means to defend itself sustainably against disease.


A woman stretching on a fitness mat.

Sources :

Fondation ARC pour la recherche sur le cancer

Institut National du Cancer (INCa), “Bénéfices de l’activité physique pendant et après cancer”, mars 2017

CAMI Sport & Cancer

La Santé en action n°445, septembre 2018

Contact us

See more

Event

MEDICA 2024 : Meet the Experts from Bioshare Solutions

Meet Bioshare Solutions at MEDICA 2024.

12 November 2024
Event

ID SOLUTIONS Oncology at the SFMPP Congress

Meet ID SOLUTIONS Oncology & our partner Diatech Pharmacogenetics at the SFMPP !

10 October 2024
pola workshop
Event

Event : POLA WORKSHOP

Meet ID SOLUTIONS Oncology at the Oligodendroglioma workshop.

19 September 2024
Event

Meet us at ESMO !

Meet ID SOLUTIONS Oncology at ESMO congress !

2 September 2024
asco congress
Event

ASCO 2024 Congress: meet the ID SOLUTIONS Oncology team!

Meeting between oncology professionals and creating partnerships (…)

27 May 2024
Lancement de produit

Liquid biopsy follow-up

Patients with advanced ER+/HER2- breast cancer treated with endocrine therapy are at greater risk of developing resistance mutations in various genes, including Estrogen Receptor 1 (ESR1).

9 April 2024

Newsletter

Sign up to keep up to date with ID SOLUTIONS news

© 2025 ID SOLUTIONS 
All rights reserved

Address

585 Rue de la Croix Verte
34090 MONTPELLIER

Phone

+33 (0)4 67 79 72 60

Opening

Monday to Friday
9h00 – 12h30 / 14h00 – 17h30

Follow us

@id-solutions

Links

About Us  |  Oncology  |  Infectiology  |  Partners

Privacy policy   |   Legal Notice